Company profile: MMJ International Holdings
1.1 - Company Overview
Company description
- Provider of pharmaceutical-grade cannabinoid formulations, including extended-release THC/CBD capsules for neurological disorders, supported by clinical trials focused on Multiple Sclerosis and Huntington's Disease. Services include DEA-compliant cannabis cultivation and extraction, educational programs for healthcare professionals, and eHealth solutions for remote monitoring, telemedicine, and patient care.
Products and services
- Cannabis Cultivation and Extraction: MMJ BioPharma Cultivation produces cannabis that meets DEA regulations for use in pharmaceutical research and development
- Clinical Trials and Research: MMJ conducts efficacy-focused clinical trials and research evaluating cannabinoid formulations for severe neurological disorders, with focus on Multiple Sclerosis and Huntington’s Disease
- Pharmaceutical Cannabinoid Formulations: MMJ International Holdings engineers pharmaceutical-grade cannabinoid formulations, including a soft-gelatin extended release capsule containing THC and CBD for treating spasticity in Multiple Sclerosis and chorea in Huntington’s Disease
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MMJ International Holdings
American Cannabis Company
HQ: United States
Website
- Description: Provider of industry-specific advisory and consulting for recreational and medical cannabis and commercial hemp, including strategic planning, financial modeling, business planning, conceptual design, and application services; operational and cultivation management; ACC brand licensing; acquisitions and equity partnerships; and manufacturing cultivation products and facilities for startups, serving domestic and international markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full American Cannabis Company company profile →
FSD Pharma
HQ: Canada
Website
- Description: Provider of Lucid-MS, a patented compound designed to prevent and reverse myelin degradation targeting Multiple Sclerosis and other neurodegenerative diseases, and UNBUZZD, a functional beverage aimed at accelerating alcohol metabolism to reduce inebriation and Breath Alcohol Concentration. Management’s mission is to transform its facility into the largest hydroponic indoor cannabis facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FSD Pharma company profile →
Hash
HQ: Canada
Website
- Description: Provider of cannabis-based products specializing in authentic, traditional hashish experiences. Delivers nostalgic hashish products; modern applications of ancient trichome separation and finishing techniques; selective breeding of heirloom hash-specific cultivars with licensed farmers; innovative cannabis resin product development; and the Hash Kettle device for traditional hashish inhalation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hash company profile →
Liberty Leaf
HQ: Canada
Website
- Description: Provider of acceleration for revenue-generating businesses in the Cannabis industry, with the objective of being at the forefront of the industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liberty Leaf company profile →
Cannabis Rx
HQ: United States
Website
- Description: Provider of commercial real estate, financing, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cannabis Rx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MMJ International Holdings
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MMJ International Holdings
2.2 - Growth funds investing in similar companies to MMJ International Holdings
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MMJ International Holdings
4.2 - Public trading comparable groups for MMJ International Holdings
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →